Alzheimer’s Disease & Clinical Trial Planning: What You Should Know

Alzheimer’s Disease is a global epidemic, and the need for patient volunteers in clinical trials is urgent. This webinar discusses how clinical trial design and conduct must adapt to the unique needs of this population to expand clinical trial acceptance and participation. Key recommendations include research with patients and caregivers, country selection, patient-friendly study designs as well as considerations to ensure patient-friendly clinical trials. The webinar also features insights from past research and global patient recruitment projects.

Key learning objectives:

        Learn more about Alzheimer’s patients and the burden of clinical trial participation

        Learn more about the caregiving community and the role they play in clinical trial participation

        Understand how current medical practices impact trial design and recruitment

About the Webinar

Guest Presenter

About Clariness 

Copyright 2016 Marcus Evans - Your Webinar Broadcaster

Karen Rosenzweig is Senior Director, US Operations. With oversight of U.S.-based projects, she is responsible for successful execution of recruitment and feasibility services. A biopharmaceutical industry veteran with more than 30 years of experience spanning all areas of drug development, Karen joined Clariness in 2012. She has served in a broad array of digital patient recruitment, project management and scientific positions at Novartis, Eisai and Ciba Geigy (later acquired by Novartis). In addition to extensive clinical trial management experience, Karen served a three-year stint as drug safety specialist, managing the reporting of adverse events for Aricept®, a landmark drug for the palliative treatment of Alzheimer’s Disease. During her tenure at Novartis, Karen successfully launched and managed two novel websites, including Investigator Portal, the industry's first global website for trial communication and documentation distribution, and, a US website for patient recruitment. Karen began her career conducting basic research in animal models where she explored novel modes of drug delivery. Karen holds a bachelor of science degree in veterinary science from Mercy College, and received an associate of applied science degree in veterinary technology from the State University of New York in Delhi, NY.


Karen Rosenzweig

Founded in 2005, Clariness is a global provider of online patient recruitment, retention, patient surveys, study feasibility and site selection services for clinical trials. Using our ClinLife® technology platform, we recruit patients efficiently, support investigative sites through the enrollment process and accelerate clinical trial start-up timelines for sponsors. With focused expertise in digital and social outreach techniques, and a team of clinical specialists, Clariness has built a reputation on global expertise, cost-effective strategies and reliable service delivery. Operational in more than 40 countries, nearly one million patients worldwide participate in our ClinLife® community.




in partnership with